Skip to content

Using Three Different Doses of Hyperbaric Prilocaine 2% Local Anaesthetic ( 40,50 and 60mg ),Through Spinal Anaesthesia in Knee Arthroscopy Patients to Compare Time to Void

Intrathecal Hyperbaric Prilocaine in Adult Patients Undergoing Knee Arthroscopy, a Randomized Controlled Trail

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06703580
Acronym
Prilocaine
Enrollment
150
Registered
2024-11-25
Start date
2024-11-30
Completion date
2026-02-08
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Time to First Void After Spinal Anaesthesia

Keywords

prilocaine, intrathecal, day case, arthroscopy, time to void

Brief summary

The goal of this randomised trial is to use a short acting local anaesthetic drug (hyperbaric prilocaine 2%) which is beneficial in short operations which are performed as a day case surgery. in this study the investigators will use 3 different doses of prilocaine 2% (40,50 or 60 mg ) intrathecal (in spinal anaesthesia) in participants undergoing arthroscopy on the knee. the primary outcome is to compare time to micturate (go to the bathroom) between the three groups . the secondary outcomes are: * time to recovery of the motor and sensory block * time to discharge from post anesthesia care unit * any complications ; itching, lowered blood pressure, nausea and vomiting.

Interventions

DRUGHyperbaric prilocaine 2% 40 mg

this arm will include 50 patients who will receive intrathecal hyperbaric prilocaine 2% in a dose of 40 mg.

DRUGhyperbaric prilocaine 2% 50 mg

comparison of 3 different doses of prilocaine

DRUGhyperbaric prilocaine 2% 60 mg

this study compare 3 different doses of prilocaine

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

All patients (male/female, American Society of Anesthesiologists physical status I-II, age: 18-60 years) undergoing knee arthroscopy will be eligible for the study. -

Exclusion criteria

1. Coagulopathy and other bleeding disorders (INR more than 1.4 and platelet less than 80000) 2. Patient refusal. 3. Infection at the site of injection. 4. Allergies against prilocaine. 5. Increased intracranial pressure. 6. Severe MS and AS. 7. Sever hypovolemia.

Design outcomes

Primary

MeasureTime frameDescription
Time to void; time from spinal anaesthesia to first voidfrom time of spinal anaesthesia as a start point till time for the participant to get up and micturate on his own (time to first void) assessed up to 4 hours postoperativewe will measure the time from spinal anaesthesia to first void and compare that in the 3 groups with different doses of hyperbaric prilocaine 2% (40,50 and 60 mg) to see which group has the least time to void and so early ambulation in a day case surgery of knee arthroscopy.

Secondary

MeasureTime frameDescription
Motor block regression timeThe motor block will be assessed 10 min after intrathecal injection as a start point and every 30 minutes until recovery of full motor power (bromage 0) up to 4 hours postoperativeMotor block will be measured by using modified bromage score, 0 = no motor block; 1 = unable to lift the extended leg in the hips; 2 = unable to flex hips and knees but still able to flex ankles; 3 = complete motor block of the lower extremity.
sensory regression timesensory regression time will be measured 10 minutes after intrathecal block (as a start point) and then every 30 minutes until regression to two dermatomes intra-operative and until 4 hours post-operative.sensory regression time will be assessed thermally with an ice- filled plastic tube and by using wooden toothpick.
heart rateheart rate will be measured in the form of beats /min from the start of operation and every 5 minutes till the end of operation
mean arterial pressuremean arterial pressure (MAP) will be measured in mmhg every 5 minutes from the start of operation till the end of operation
Incidence of complicationsincidence of complications will be recorded from the start of operation till discharge from post anaesthesia care unit (PACU) assessed up to 4 hoursincidence of hypotension, bradycardia, nausea, vomiting , headache or pruritis if it occurred or not ( as a yes or no)
Time to discharge from post operative anaesthesia unit (PACU)time will be recorded from the start of operation till discharge of the participant from PACU after reaching Aldrete score of 10 (up to 4 hours postoperative)

Countries

Egypt

Contacts

STUDY_CHAIRosama M Asad, professor of anaesthesia

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026